Systematic review: The placebo effect of psychological interventions in the treatment of irritable bowel syndrome
- PMID: 28405151
- PMCID: PMC5374135
- DOI: 10.3748/wjg.v23.i12.2223
Systematic review: The placebo effect of psychological interventions in the treatment of irritable bowel syndrome
Abstract
Aim: To determine the placebo response rate associated with different types of placebo interventions used in psychological intervention studies for irritable bowel syndrome.
Methods: Randomized controlled trials comparing psychological interventions (stress management/relaxation therapy (cognitive) behavioral therapy, short-term psychodynamic therapy, and hypnotherapy) for the treatment of adult patients with irritable bowel syndrome (IBS) diagnosed with the Manning or Rome criteria with an adequate placebo control treatment and reporting data on IBS symptom severity were identified by searching PubMed, Embase, the Cochrane Library, CINAHL and PsycINFO databases. Full-text articles that were written in English and published between 1966 and February 2016 in peer-reviewed journals were selected for the present review. Placebo interventions were considered to be adequate if the number of sessions and the amount of time spent with the therapist were the same as in the active treatment. The placebo response rate (PRR) was computed for IBS symptom severity (primary outcome measure) as well as for anxiety, depression and quality of life (secondary outcome measures).
Results: Six studies, with a total of 555 patients met the inclusion criteria. Four studies used an educational intervention, whereas two studies used a form of supportive therapy as the placebo intervention. The PRR for IBS symptom severity ranged from 25% to 59%, with a pooled mean of 41.4%. The relative PRR for the secondary outcome measures ranged from 0% to 267% for anxiety, 6% to 52% for depression 20% to 125% for quality of life. The PRR associated with pharmacological treatments, treatment with dietary bran and complementary medicine ranged from 37.5% to 47%. Contrary to our expectations, the PRR in studies on psychological interventions was comparable to that in studies on pharmacological, dietary and alternative medical interventions.
Conclusion: The PRR is probably determined to a larger extent by patient-related factors, such as expectations and desire for the treatment to be effective, than the content of the placebo intervention.
Keywords: Irritable bowel syndrome; Placebo effect; Psychological interventions; Systematic review.
Conflict of interest statement
Conflict-of-interest statement: None of the authors has any conflict of interest.
Figures


Similar articles
-
Dietary interventions for recurrent abdominal pain in childhood.Cochrane Database Syst Rev. 2017 Mar 23;3(3):CD010972. doi: 10.1002/14651858.CD010972.pub2. Cochrane Database Syst Rev. 2017. PMID: 28334433 Free PMC article.
-
Physical activity for treatment of irritable bowel syndrome.Cochrane Database Syst Rev. 2022 Jun 29;6(6):CD011497. doi: 10.1002/14651858.CD011497.pub2. Cochrane Database Syst Rev. 2022. PMID: 35766861 Free PMC article.
-
Psychological treatments for the management of irritable bowel syndrome.Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006442. doi: 10.1002/14651858.CD006442.pub2. Cochrane Database Syst Rev. 2009. PMID: 19160286
-
Hypnotherapy for treatment of irritable bowel syndrome.Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005110. doi: 10.1002/14651858.CD005110.pub2. Cochrane Database Syst Rev. 2007. PMID: 17943840
-
Acupuncture for treatment of irritable bowel syndrome.Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005111. doi: 10.1002/14651858.CD005111.pub2. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2012 May 16;(5):CD005111. doi: 10.1002/14651858.CD005111.pub3. PMID: 17054239 Updated.
Cited by
-
Hypnotherapy for irritable bowel syndrome: patient expectations and perceptions.Therap Adv Gastroenterol. 2022 Feb 15;15:17562848221074208. doi: 10.1177/17562848221074208. eCollection 2022. Therap Adv Gastroenterol. 2022. PMID: 35198040 Free PMC article.
-
Diagnosis of Irritable Bowel Syndrome: Primary Care Physicians Compared with Gastroenterologists.Clin Med Res. 2023 Sep;21(3):129-135. doi: 10.3121/cmr.2023.1817. Clin Med Res. 2023. PMID: 37985167 Free PMC article.
-
Electro-acupuncture for irritable bowel syndrome patients: study protocol for a single-blinded randomized sham-controlled clinical trial.Trials. 2021 Sep 15;22(1):619. doi: 10.1186/s13063-021-05563-4. Trials. 2021. PMID: 34526079 Free PMC article.
-
Cohort Profile: The Christchurch IBS cOhort to investigate Mechanisms FOr gut Relief and improved Transit (COMFORT).Inflamm Intest Dis. 2020 Aug;5(3):132-143. doi: 10.1159/000508160. Epub 2020 Jul 8. Inflamm Intest Dis. 2020. PMID: 32999886 Free PMC article.
-
Effects of vitamin D3 supplementation on clinical symptoms, quality of life, serum serotonin (5-hydroxytryptamine), 5-hydroxy-indole acetic acid, and ratio of 5-HIAA/5-HT in patients with diarrhea-predominant irritable bowel syndrome: A randomized clinical trial.EXCLI J. 2020 May 19;19:652-667. doi: 10.17179/excli2020-2247. eCollection 2020. EXCLI J. 2020. PMID: 33013260 Free PMC article.
References
-
- Brandt LJ, Chey WD, Foxx-Orenstein AE, Schiller LR, Schoenfeld PS, Spiegel BM, Talley NJ, Quigley EM. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol. 2009;104 Suppl 1:S1–35. - PubMed
-
- Quartero AO, Meineche-Schmidt V, Muris J, Rubin G, de Wit N. Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2005;(2):CD003460. - PubMed
-
- Zijdenbos IL, de Wit NJ, van der Heijden GJ, Rubin G, Quartero AO. Psychological treatments for the management of irritable bowel syndrome. Cochrane Database Syst Rev. 2009;(1):CD006442. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous